People with thrombotic thrombocytopenic purpura (TTP) who are hospitalized on weekends face no increased risk of worse outcomes than those admitted on weekdays, according…
Thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura is a rare, life-threatening blood disorder marked by dangerous clotting and low platelet counts. Prompt diagnosis and treatment are critical, and with proper care, most people recover and avoid serious complications.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Latest news
A lack or delayed response to Cablivi (caplacizumab-yhdp), when used alongside standard therapy to treat acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP), was…